Stock chart
Ticker: ADVM Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-04-02 2025-04-02 B Purchase

Leonard Braden Michael

Large shareholder
1,000 +0.6%
4.04
USD 61,408
1,000 +0.6% 4.04 USD 100,000
2025-04-02 2025-03-31 B Purchase

Leonard Braden Michael

Large shareholder
1,000 +0.7%
4.38
USD 85,668
1,000 +0.7% 4.38 USD 100,000
2025-03-27 2025-03-26 B Purchase

Leonard Braden Michael

Large shareholder
1,000 +19.5%
5.04
USD 102,841
1,000 +19.5% 5.04 USD 100,000
2025-03-20 2025-03-20 B Purchase

Leonard Braden Michael

Large shareholder
30,600 +1.1%
5.61
USD 171,767
30,600 +1.1% 5.61 USD 171,767
2025-03-20 2025-03-19 B Purchase

Leonard Braden Michael

Large shareholder
25,000 +0.9%
4.94
USD 123,390
25,000 +0.9% 4.94 USD 123,390
2025-03-20 2025-03-18 B Purchase

Leonard Braden Michael

Large shareholder
44,341 +1.7%
4.73
USD 209,618
44,341 +1.7% 4.73 USD 209,618
2025-03-20 2025-03-18 B Purchase

Leonard Braden Michael

Large shareholder
18,000 +0.7%
4.60
USD 82,800
18,000 +0.7% 4.60 USD 82,800
2025-02-28 2025-02-28 B Purchase

Leonard Braden Michael

Large shareholder
85,068 +3.4%
4.60
USD 391,015
85,068 +3.4% 4.60 USD 391,015
2025-02-28 2025-02-27 B Purchase

Leonard Braden Michael

Large shareholder
86,802 +3.6%
4.46
USD 387,094
86,802 +3.6% 4.46 USD 387,094
2025-02-28 2025-02-26 B Purchase

Leonard Braden Michael

Large shareholder
164,886 +7.3%
4.01
USD 660,979
164,886 +7.3% 4.01 USD 660,979
2024-07-31 2024-07-30 B Purchase

Leonard Braden Michael

Large shareholder
85,800 +3.9%
7.15
USD 613,470
85,800 +3.9% 7.15 USD 613,470
2024-07-18 2024-07-18 B Purchase

Leonard Braden Michael

Large shareholder
80,718 +3.8%
9.11
USD 735,736
80,718 +3.8% 9.11 USD 735,736
2024-07-18 2024-07-17 B Purchase

Leonard Braden Michael

Large shareholder
135,546 +6.9%
7.75
USD 1,049,926
135,546 +6.9% 7.75 USD 1,049,926
2024-02-09 2024-02-07 B Purchase

Scopa James Paul

Non-Executive Director
100,000 +inf%
1.35
USD 135,000
100,000 +inf% 1.35 USD 135,000
2024-02-09 2024-02-07 B Purchase

Lupher, Jr. Mark L.

Non-Executive Director
130,000 +inf%
1.35
USD 175,500
130,000 +inf% 1.35 USD 175,500
2023-09-18 2023-09-15 S Sale

Seyedkazemi Setareh

Chief Development Officer

Officer
130 -0.3%
1.55
USD 201
130 -0.3% 1.55 USD 201
2023-09-18 2023-09-15 PS Planned sale

Seyedkazemi Setareh

Chief Development Officer

Officer
6,071 -11.3%
1.52
USD 9,228
6,071 -11.3% 1.52 USD 9,228
2023-06-09 2023-06-07 B Purchase

Rubinstein Linda M

Chief Financial Officer

Officer
100,000 +inf%
1.45
USD 145,490
100,000 +inf% 1.45 USD 145,490
2023-03-17 2023-03-15 PS Planned sale

Soparkar Peter

Chief Operating Officer

Officer
13,360 -4.8%
0.78
USD 10,442
13,360 -4.8% 0.78 USD 10,442
2023-03-17 2023-03-15 PS Planned sale

Fischer Laurent

CEO, President and Director

Executive Director
41,239 -5.6%
0.78
USD 32,232
41,239 -5.6% 0.78 USD 32,232
2023-03-17 2023-03-15 PS Planned sale

Riley Brigit

Chief Scientific Officer

Officer
7,299 -5.9%
0.78
USD 5,705
7,299 -5.9% 0.78 USD 5,705
2022-09-21 2022-09-19 PS Planned sale

Fischer Laurent

CEO, President and Director

Executive Director
41,082 -5.3%
1.07
USD 43,941
41,082 -5.3% 1.07 USD 43,941
2022-09-21 2022-09-19 PS Planned sale

Soparkar Peter

See Remarks section

Officer
13,305 -4.6%
1.07
USD 14,232
13,305 -4.6% 1.07 USD 14,232
2022-09-21 2022-09-19 PS Planned sale

Riley Brigit

Chief Scientific Officer

Officer
7,266 -5.8%
1.07
USD 7,772
7,266 -5.8% 1.07 USD 7,772
2022-09-21 2022-09-19 S Sale

Seyedkazemi Setareh

Chief Development Officer

Officer
6,058 -11.2%
1.07
USD 6,480
6,058 -11.2% 1.07 USD 6,480
2022-09-21 2022-09-19 S Sale

Beckman Richard

Chief Medical Officer

Officer
4,272 -9.9%
1.07
USD 4,570
4,272 -9.9% 1.07 USD 4,570
2022-05-24 2022-05-23 B Purchase

Seyedkazemi Setareh

Chief Development Officer

Officer
20,000 +3333.3%
0.84
USD 16,800
20,000 +3333.3% 0.84 USD 16,800
2022-05-19 2022-05-17 B Purchase

Beckman Richard

Chief Medical Officer

Officer
10,000 +inf%
0.82
USD 8,228
10,000 +inf% 0.82 USD 8,228
2022-05-17 2022-05-17 B Purchase

D'Souza Rupert

Chief Financial Officer

Officer
10,000 +92.2%
0.83
USD 8,272
10,000 +92.2% 0.83 USD 8,272
2022-05-18 2022-05-16 B Purchase

Svoronos Dawn

Non-Executive Director
30,000 +150.0%
0.85
USD 25,578
30,000 +150.0% 0.85 USD 25,578
2022-05-17 2022-05-13 B Purchase

D'Souza Rupert

Chief Financial Officer

Officer
10,000 +1176.5%
0.86
USD 8,585
10,000 +1176.5% 0.86 USD 8,585
2022-04-22 2022-04-20 B Purchase

Fischer Laurent

CEO, President and Director

Executive Director
25,000 +3.4%
1.11
USD 27,800
25,000 +3.4% 1.11 USD 27,800
2022-04-20 2022-04-19 B Purchase

Soparkar Peter

See Remarks section

Officer
21,750 +8.4%
1.14
USD 24,795
21,750 +8.4% 1.14 USD 24,795
2022-04-20 2022-04-19 B Purchase

Soparkar Peter

See Remarks section

Officer
175 +0.1%
1.14
USD 199
175 +0.1% 1.14 USD 199
2021-12-10 2021-12-09 B Purchase

Fischer Laurent

CEO, President and Director

Executive Director
14,323 +2.0%
1.85
USD 26,498
14,323 +2.0% 1.85 USD 26,498
2021-12-10 2021-12-08 PP Planned purchase

Fischer Laurent

CEO, President and Director

Executive Director
10,677 +1.5%
1.79
USD 19,112
10,677 +1.5% 1.79 USD 19,112
2021-12-10 2021-12-08 PP Planned purchase

Soparkar Peter

See Remarks section

Officer
25,000 +10.7%
1.91
USD 47,750
25,000 +10.7% 1.91 USD 47,750
2021-11-17 2021-11-15 S Sale

Scopa James Paul

Non-Executive Director
50,000 -93.7%
2.18
USD 109,000
50,000 -93.7% 2.18 USD 109,000
2021-10-04 2021-09-30 S Sale

Clark Julie

Chief Medical Officer

Officer
4,766 -2.8%
2.17
USD 10,342
4,766 -2.8% 2.17 USD 10,342
2021-04-01 2021-03-31 B Purchase

Svoronos Dawn

Non-Executive Director
20,000 +inf%
10.02
USD 200,338
20,000 +inf% 10.02 USD 200,338
2021-03-24 2021-03-24 B Purchase

Machado Patrick

Non-Executive Director
10,000 +12.8%
9.92
USD 99,196
10,000 +12.8% 9.92 USD 99,196
2021-03-24 2021-03-24 B Purchase

Fischer Laurent

CEO and Director

Executive Director
10,000 +61.4%
9.88
USD 98,780
10,000 +61.4% 9.88 USD 98,780
2021-02-11 2021-02-09 S Sale

PATTERSON LEONE D

President and CFO

Officer
62 -0.1%
14.14
USD 877
62 -0.1% 14.14 USD 877
2021-02-11 2021-02-09 S Sale

PATTERSON LEONE D

President and CFO

Officer
12,471 -11.3%
14.10
USD 175,841
12,471 -11.3% 14.10 USD 175,841
2021-01-19 2021-01-15 B Purchase

Machado Patrick

Non-Executive Director
10,000 +14.7%
11.52
USD 115,174
10,000 +14.7% 11.52 USD 115,174
2021-01-19 2021-01-15 B Purchase

Fischer Laurent

CEO and Director

Executive Director
8,600 +111.8%
11.53
USD 99,191
8,600 +111.8% 11.53 USD 99,191
2020-08-19 2020-08-17 PP Planned purchase

Soparkar Peter

Chief Legal Officer

Officer
7,692 +256.4%
13.00
USD 99,996
7,692 +256.4% 13.00 USD 99,996
2020-08-19 2020-08-17 B Purchase

Fischer Laurent

CEO and Director

Executive Director
7,692 +inf%
13.00
USD 99,996
7,692 +inf% 13.00 USD 99,996
2020-07-22 2020-07-20 PS Planned sale

Gasmi Mehdi

Non-Executive Director
5,000 -1.8%
17.60
USD 87,978
5,000 -1.8% 17.60 USD 87,978
2020-06-23 2020-06-22 PS Planned sale

Gasmi Mehdi

Non-Executive Director
23,605 -7.9%
25.06
USD 591,617
23,605 -7.9% 25.06 USD 591,617
2020-06-18 2020-06-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
11,127 -3.9%
25.01
USD 278,329
11,127 -3.9% 25.01 USD 278,329
2020-06-18 2020-06-17 PS Planned sale

Gasmi Mehdi

Non-Executive Director
268 -0.1%
25.01
USD 6,703
268 -0.1% 25.01 USD 6,703
2020-06-17 2020-06-16 S Sale

PATTERSON LEONE D

President

Officer
13,171 -10.7%
24.68
USD 325,060
13,171 -10.7% 24.68 USD 325,060
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
159 -0.1%
23.59
USD 3,751
159 -0.1% 23.59 USD 3,751
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
3,425 -1.2%
23.00
USD 78,787
3,425 -1.2% 23.00 USD 78,787
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
1,416 -0.5%
21.93
USD 31,047
1,416 -0.5% 21.93 USD 31,047
2020-06-17 2020-06-15 PS Planned sale

Gasmi Mehdi

Non-Executive Director
5,000 -1.8%
21.01
USD 105,042
5,000 -1.8% 21.01 USD 105,042
2020-05-22 2020-05-20 PS Planned sale

Gasmi Mehdi

Non-Executive Director
1,401 -0.5%
20.01
USD 28,030
1,401 -0.5% 20.01 USD 28,030
2020-05-20 2020-05-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
300 -0.1%
19.03
USD 5,709
300 -0.1% 19.03 USD 5,709
2020-05-20 2020-05-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
4,700 -1.7%
18.11
USD 85,124
4,700 -1.7% 18.11 USD 85,124
2020-05-20 2020-05-06 PS Planned sale

Gasmi Mehdi

Non-Executive Director
25,000 -8.3%
20.03
USD 500,668
25,000 -8.3% 20.03 USD 500,668
2020-05-08 2020-05-06 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
20,000 -13.9%
20.02
USD 400,400
20,000 -13.9% 20.02 USD 400,400
2020-05-20 2020-05-05 PS Planned sale

Gasmi Mehdi

Non-Executive Director
10,000 -3.5%
16.26
USD 162,573
10,000 -3.5% 16.26 USD 162,573
2020-03-25 2020-03-20 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
39,526 -24.3%
10.17
USD 401,908
39,526 -24.3% 10.17 USD 401,908
2020-03-18 2020-03-17 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
474 -0.3%
10.02
USD 4,749
474 -0.3% 10.02 USD 4,749
2020-02-20 2020-02-18 PS Planned sale

Gasmi Mehdi

Non-Executive Director
5,000 -1.9%
16.23
USD 81,156
5,000 -1.9% 16.23 USD 81,156
2020-02-14 2020-02-14 B Purchase

Scopa James Paul

Non-Executive Director
10,000 +50.0%
13.75
USD 137,500
10,000 +50.0% 13.75 USD 137,500
2020-02-14 2020-02-12 PS Planned sale

Gasmi Mehdi

Non-Executive Director
10,000 -3.7%
15.07
USD 150,690
10,000 -3.7% 15.07 USD 150,690
2019-12-26 2019-12-23 PS Planned sale

PATTERSON LEONE D

CEO, President and Director

Executive Director
40,000 -14.9%
10.72
USD 428,800
40,000 -14.9% 10.72 USD 428,800
2019-05-06 2019-05-06 B Purchase

Scopa James Paul

Non-Executive Director
20,000 +inf%
6.71
USD 134,200
20,000 +inf% 6.71 USD 134,200
2015-06-17 2015-06-15 PS Planned sale

Gasmi Mehdi

SVP,Pharmaceutical Development

Officer
500 -6.7%
39.86
USD 19,931
500 -6.7% 39.86 USD 19,931
2015-06-15 2015-06-12 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
3,500 -28.0%
39.94
USD 139,795
3,500 -28.0% 39.94 USD 139,795
2015-06-11 2015-06-10 PS Planned sale

Chalberg Thomas W.

Chief Executive Officer

Executive Director
6,995 -2.6%
38.90
USD 272,123
6,995 -2.6% 38.90 USD 272,123
2015-06-11 2015-06-10 PS Planned sale

Chalberg Thomas W.

Chief Executive Officer

Executive Director
12,970 -4.6%
38.04
USD 493,339
12,970 -4.6% 38.04 USD 493,339
2015-06-11 2015-06-10 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
600 -0.1%
39.91
USD 23,948
600 -0.1% 39.91 USD 23,948
// ... existing code ... // ... rest of the file ...